MMAE-SMCC is a drug-linker conjugate for ADC. MMAE-SMCC is composed of a highly potent mitotic and a tubulin inhibitor MMAE and a linker SMCC to make antibody drug conjugate. References: [1]. Tang F, et al. One-pot N-glycosylation remodeling of IgG with non-natural sialylglycopeptides enables glycosite-specific and dual-payload antibody-drug conjugates. Org Biomol Chem. 2016 Oct 12;14(40):9501-9518.

纯度：≥98%

CAS：2021179-11-1